What is the immediate treatment for an anaphylactic reaction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Treatment for Anaphylactic Reaction

Administer intramuscular epinephrine immediately—this is the only first-line treatment for anaphylaxis and delays in administration are directly associated with fatalities. 1, 2, 3

Primary Treatment: Epinephrine

Epinephrine must be given intramuscularly into the anterolateral thigh (vastus lateralis) at the first recognition of anaphylaxis. 1, 2, 4

Dosing

  • Adults and children ≥30 kg: 0.3-0.5 mg of 1:1000 concentration (0.3-0.5 mL) 4
  • Children <30 kg: 0.01 mg/kg (maximum 0.3 mg) 1, 2
  • Repeat every 5-10 minutes as necessary if symptoms persist or recur 1, 4

Critical Route Considerations

Intramuscular injection in the thigh produces significantly higher peak plasma epinephrine concentrations more rapidly than subcutaneous administration or injection in the arm. 1 The FDA-approved epinephrine formulation has no absolute contraindications for anaphylaxis. 4

Supportive Measures (After Epinephrine)

Fluid Resuscitation

  • Administer crystalloid fluid bolus immediately: 0.5-1 L rapid bolus for adults (20 mL/kg for children), repeated as needed for persistent hypotension 1
  • Large volumes may be necessary due to vasodilatation and capillary leakage 1

Patient Positioning

  • Place patient supine with legs elevated (if tolerated) 1
  • In pregnant patients, ensure left uterine displacement to avoid aortocaval compression 1

Adjunct Medications (Second-Line Only)

H1 Antihistamines

Antihistamines should never be used alone or as initial treatment—they only address cutaneous manifestations and have slow onset (30-60 minutes). 2, 3 After adequate epinephrine and stabilization, diphenhydramine 25-50 mg IV/IM may be given. 2, 3

Corticosteroids

Glucocorticoids have no role in acute anaphylaxis due to their 4-6 hour minimum onset of action and do not prevent biphasic reactions. 3 They may be considered only after epinephrine and stabilization in patients with severe/prolonged anaphylaxis, history of idiopathic anaphylaxis, or underlying asthma. 2, 3

Management of Refractory Anaphylaxis

If inadequate response after 10 minutes despite adequate epinephrine and fluids:

  • Escalate epinephrine: Double the bolus dose or start epinephrine infusion (0.05-0.1 mcg/kg/min) after three bolus doses 1
  • Add alternative vasopressors: Norepinephrine, vasopressin (1-2 IU bolus), phenylephrine, or metaraminol for persistent hypotension 1
  • For patients on beta-blockers: Administer IV glucagon 1-2 mg 1, 2
  • For persistent bronchospasm: Inhaled bronchodilators (albuterol), consider IV bronchodilators or volatile anesthetics 1

Cardiac Arrest

Follow advanced life support guidelines with IV epinephrine 1 mg boluses. 1 Consider extracorporeal life support if available and skills permit. 1

Post-Resuscitation Monitoring

All patients must be observed in a monitored area for minimum 6 hours from reaction onset due to risk of biphasic reactions (recurrence without re-exposure). 1 Risk factors for biphasic reactions include severe initial anaphylaxis and requirement for multiple epinephrine doses. 1

Mast Cell Tryptase Sampling

  • First sample at 1 hour after reaction onset 1
  • Second sample at 2-4 hours 1
  • Baseline sample ≥24 hours post-reaction for comparison 1

Critical Pitfalls to Avoid

  • Never delay epinephrine for antihistamines or corticosteroids—this is the most common fatal error 2, 3, 5
  • Never use subcutaneous route—absorption is delayed compared to intramuscular 1
  • Never inject into buttocks, digits, hands, or feet—risk of tissue injury 4
  • Never administer IV epinephrine outside monitored settings—reserve only for cardiac arrest or profound hypotension unresponsive to IM epinephrine 2, 3
  • Never rely on antihistamines alone—they cannot address cardiovascular collapse or respiratory distress 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anaphylaxis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.